Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,203 | 3,735 | -5,431 | -7,329 | -7,948 |
| Depreciation Amortization | 253 | 284 | 268 | 326 | 395 |
| Accounts receivable | -143 | -88 | 411 | -164 | -626 |
| Accounts payable and accrued liabilities | 222 | 848 | -10 | 158 | -266 |
| Other Working Capital | -2,365 | -332 | 3,125 | -83 | 464 |
| Other Operating Activity | 3,542 | -9,337 | 2,787 | 3,060 | 3,552 |
| Operating Cash Flow | $-6,694 | $-4,890 | $1,150 | $-4,032 | $-4,429 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -139 | -504 | -257 | -336 | -174 |
| Purchase Of Investment | 51 | 59 | -113 | -24 | 10 |
| Sale Of Investment | 963 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $875 | $-445 | $-370 | $-360 | $-164 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,500 | 3,000 |
| Debt Repayment | -176 | -1,615 | -2,083 | -1,164 | -410 |
| Common Stock Issued | 6,785 | 4,483 | 4,970 | 2,113 | 94 |
| Other Financing Activity | 0 | 77 | 863 | 0 | 0 |
| Financing Cash Flow | $6,609 | $2,945 | $3,750 | $3,449 | $2,684 |
| Exchange Rate Effect | -134 | -30 | 19 | -77 | 22 |
| Beginning Cash Position | 5,480 | 7,900 | 3,351 | 4,371 | 6,258 |
| End Cash Position | 6,136 | 5,480 | 7,900 | 3,351 | 4,371 |
| Net Cash Flow | $656 | $-2,420 | $4,549 | $-1,020 | $-1,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,694 | -4,890 | 1,150 | -4,032 | -4,429 |
| Capital Expenditure | -139 | -504 | -257 | -336 | -174 |
| Free Cash Flow | -6,833 | -5,394 | 893 | -4,368 | -4,603 |